Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial. (Record no. 21268680)

MARC details
000 -LEADER
fixed length control field 01641 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516062355.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201207s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1432-0843
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s00280-011-1773-y
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Reardon, David A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120727
245 00 - TITLE STATEMENT
Title Ridaforolimus for patients with progressive or recurrent malignant glioma: a perisurgical, sequential, ascending-dose trial.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer chemotherapy and pharmacology
Date of publication, distribution, etc. Apr 2012
300 ## - PHYSICAL DESCRIPTION
Extent 849-60 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotics, Antineoplastic
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cohort Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Combined Modality Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glioma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunohistochemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Maximum Tolerated Dose
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Sirolimus
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wen, Patrick Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Alfred Yung, W K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Berk, Lori
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Narasimhan, Narayana
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Turner, Christopher D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Clackson, Timothy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rivera, Victor M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vogelbaum, Michael A
773 0# - HOST ITEM ENTRY
Title Cancer chemotherapy and pharmacology
Related parts vol. 69
-- no. 4
-- p. 849-60
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s00280-011-1773-y">https://doi.org/10.1007/s00280-011-1773-y</a>
Public note Available from publisher's website

No items available.